Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs.
R. Vivek had received his M. Sc and PhD degree from Bharathiar University. He did PhD programme in the following areas. His research focuses on advance nanotechnology research for cancer prevention, diagnosis, and treatment. In this context, His Ph.D work is pertaining to develop an innovative method to deliver drug of in "Nanomedicine"
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Vivek RajuR. Vivek had received his M. Sc and PhD degree from Bharathiar University. He did PhD programme in the following areas. His research focuses on advance nanotechnology research for cancer prevention, diagnosis, and treatment. N° de réf. du vendeur 4999084
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs. 592 pp. Englisch. N° de réf. du vendeur 9783639707601
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Nanoparticles for Cancer Theraphy | Raju Vivek (u. a.) | Taschenbuch | 592 S. | Englisch | 2014 | Scholars' Press | EAN 9783639707601 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 105482718
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 592 pp. Englisch. N° de réf. du vendeur 9783639707601
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs. N° de réf. du vendeur 9783639707601
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. pp. 592. N° de réf. du vendeur 26127709870
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand pp. 592 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam. N° de réf. du vendeur 132844913
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND pp. 592. N° de réf. du vendeur 18127709860
Quantité disponible : 4 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 592 pages. 8.66x5.91x1.34 inches. In Stock. N° de réf. du vendeur __3639707605
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 592 pages. 8.66x5.91x1.34 inches. In Stock. N° de réf. du vendeur 3639707605
Quantité disponible : 1 disponible(s)